6487-38-3
6487-38-3
Chemical Structure
3-Hydroxypropionic acid sodium
- CAS No.: 6487-38-3
- Formula:C3H5NaO3
- Molecular Weight:112.06
IUPAC Name: N-(3-(((S,Z)-3-(2-((1R,3aS,7aR,E)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexyl)oxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide
InChIKey: AVXDKPABPXSLIZ-UHFFFAOYSA-M
SMILES: O=C(CCO)O[Na]
Biological Activity: 3-Hydroxypropionic acid sodium is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid sodium exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid sodium can be used in studies related to nocturia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Hydroxypropionic acid sodium | 99.34% | 3-Hydroxypropionic acid sodium is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid sodium exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid sodium can be used in studies related to nocturia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Hydroxypropionic acid-13C3 sodium | 3-Hydroxypropionic acid-13C3 sodium is the 13C labeled 3-Hydroxypropionic acid sodium (HY-W095705A). 3-Hydroxypropionic acid sodium, an endogenous metabolite, is a building block in the chemical synthesis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Hydroxypropionic acid-d4 sodium | 98.0% | 3-Hydroxypropionic acid-d4 sodium is the deuterium labeled 3-Hydroxypropionic acid sodium (HY-W095705A). 3-Hydroxypropionic acid sodium, an endogenous metabolite, is a building block in the chemical synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hydroxy-PEG1-acid sodium salt | Hydroxy-PEG1-acid sodium is a PEG linker containing a hydroxyl group with a terminal carboxylic acid (as sodium salt form). The free acid form is not stable due to the reaction of OH with PEG-COOH group to form polymer. The sodium salt form is stable for storage and shipping. The hydrophilic PEG spacer increases solubility in aqueous media. The hydroxyl group enables further derivatization or replacement with other reactive functional groups. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sodium 4-pentynoate | ≥98.0% | Sodium 4-pentynoate is a alkynylacetate analogue, can be metabolically incorporated onto cellular proteins through biosynthetic mechanisms for profiling of acetylated proteins in diverse cell types. Sodium 4-pentynoate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl 3-hydroxypropanoate | 99.82% | Methyl 3-hydroxypropanoate is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sodium butyrate | 99.76% | Sodium butyrate ((Butanoic acid; Butyric acid) sodium) is an orally active HDAC inhibitor. Sodium butyrate induces hyperacetylation of core histones and affects phosphorylation of H1/H2A, thereby altering chromatin structure and regulating gene expression. Sodium butyrate can be used in research related to various cancers, inflammatory bowel disease, and sickle cell anemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Valerate sodium | 98% | Valerate sodium is the sodium salt of valeric acid, a short-chain fatty acid, and exhibits oral activity. Valerate sodium reduces binge ethanol intake and decreases blood ethanol concentration in mice, while also exerting anxiolytic effects. Valerate sodium increases GABA levels, regulates epigenetics and alters gut microbiome function. Valerate sodium can be used in research related to excessive alcohol consumption. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sodium glycolate, 98% | 98.0% | Sodium glycolate, 98% (Sodium hydroxyacetate, 98%) is an orally active, versatile organic salt. Sodium glycolate, 98% acts as an enzyme activity regulator that increases the activities of glycolate oxidase (GAO) and lactate dehydrogenase (LDH), while reducing the activity of glycolate dehydrogenase (GAD). Sodium glycolate, 98% induces oxalate biosynthesis and causes hyperoxaluria in rats. Sodium glycolate, 98% reduces urinary calcium excretion in male albino rats. Sodium glycolate, 98% can be used in studies related to calcium oxalate urolithiasis and hyperoxaluria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Hydroxypropionic acid (30% in water) | 3-Hydroxypropionic acid (30% in water) is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid (30% in water) exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid (30% in water) can be used in studies related to nocturia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Hydroxypentanoate sodium | 98.0% | 4-Hydroxypentanoate sodium, a sedative, is an active metabolite of gamma-Valerolactone (HY-W015938). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(S)-3,4-Dihydroxybutyric acid sodium | (S)-3,4-Dihydroxybutyric acid sodium is a normal human urinary metabolite that is excreted in increased concentration in patients with succinic semialdehyde dehydrogenase (SSADH) deficiency. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Butyric acid-13C4 sodium | 99.6% | Butyric acid-13C4 sodium (Butyric acid-13C4 sodium) is a stable isotope labeled compound with the activity of promoting cell proliferation and regulating gene expression. Butyric acid-13C4 sodium can be used in metabolic research and compound development to help scientists gain a deeper understanding of the role of short-chain fatty acids in organisms. Butyric acid-13C4 sodium also plays an important role in nutrition and intestinal health research, especially in the regulation of probiotic function and intestinal microbiota. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Liang B, et al. Recent advances, challenges and metabolic engineering strategies in the biosynthesis of 3-hydroxypropionic acid. Biotechnology and bioengineering. 2022 Oct;119(10):2639-2668. [Content Brief]
- [2]. Kira S, et al. Urinary metabolites identified using metabolomic analysis as potential biomarkers of nocturia in elderly men. World journal of urology. 2020 Oct;38(10):2563-2569. [Content Brief]
